Congcong Lin
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 5
- Epigenetics and DNA Methylation 3
- Oncology 7
- Peptidase Inhibition and Analysis 3
- Co-authors
- Zhijun Yang (9 shared papers)Aiping Lü (9 shared papers)Ge Zhang (5 shared papers)Muhammad Kashif Riaz (4 shared papers)Liang Ouyang (7 shared papers)Jifa Zhang (7 shared papers)Xiaoyu Chen (2 shared papers)Muhammad Adil Riaz (1 shared paper)
- Journals
- International Journal of Pharmaceutics (5 papers)European Journal of Medicinal Chemistry (4 papers)Journal of Controlled Release (3 papers)Drug Delivery (2 papers)Acta Pharmaceutica Sinica B (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Congcong Lin
37 papers receiving 1.7k citations
Congcong Lin's Hit Papers
Peers
Comparison fields: 5 of 111
- Biomaterials 526
- Pharmaceutical Science 214
- Molecular Medicine 66
- Molecular Biology 839
- Biomedical Engineering 343
Countries citing papers authored by Congcong Lin
This map shows the geographic impact of Congcong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congcong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congcong Lin more than expected).
Fields of papers citing papers by Congcong Lin
This network shows the impact of papers produced by Congcong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congcong Lin. The network helps show where Congcong Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Congcong Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review Hit paper breakdown → | 2018 | 416 |
| 2 | 2019 | 190 | |
| 3 | 2022 | 132 | |
| 4 | 2018 | 105 | |
| 5 | 2016 | 93 | |
| 6 | 2017 | 89 | |
| 7 | 2015 | 78 | |
| 8 | 2020 | 73 | |
| 9 | 2022 | 68 | |
| 10 | 2017 | 48 | |
| 11 | 2014 | 46 | |
| 12 | 2020 | 42 | |
| 13 | 2015 | 36 | |
| 14 | 2022 | 31 | |
| 15 | 2023 | 31 | |
| 16 | 2017 | 24 | |
| 17 | 2014 | 24 | |
| 18 | 2022 | 22 | |
| 19 | 2021 | 20 | |
| 20 | 2017 | 17 |
About Congcong Lin
Congcong Lin is a scholar working on Molecular Biology, Oncology, Biomaterials, Cancer Research and Surgery, having authored 39 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), RNA Interference and Gene Delivery (5 papers), Epigenetics and DNA Methylation (3 papers), Peptidase Inhibition and Analysis (3 papers), Advanced Drug Delivery Systems (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Drug Solubulity and Delivery Systems (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Biomaterials (526 citations), Pharmaceutical Science (214 citations), Molecular Medicine (66 citations), Molecular Biology (839 citations) and Biomedical Engineering (343 citations). Congcong Lin has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Zhijun Yang, Aiping Lü, Ge Zhang, Muhammad Kashif Riaz, Liang Ouyang, Jifa Zhang, Xiaoyu Chen, Muhammad Adil Riaz, Ka Hong Wong and Lan Zhang. Their work appears in journals such as International Journal of Pharmaceutics, European Journal of Medicinal Chemistry, Journal of Controlled Release, Drug Delivery and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.